---
title: Mike Steigerwald shared a link.
date: '2018-07-06T19:09:46.000Z'
platform: facebook
source_file: your_posts__check_ins__photos_and_videos_1.json
---
The skyrocketing cost of Acthar led to huge increases in revenues for the drugmakers, Questcor and Mallinckrodt, not because of any breakthrough in treatment, critics say, but as a result of higher prices, aggressive marketing and an alleged effort to thwart all competition.
